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IN THOSE HAVING REGIONAL LYMPH NODE DISSECTION 
Kohei HASHIMOT01， Shin-ichi HISASUE1， Masahiro YANASE2， 
Atsushi TAKAHASHI1， Toshihiro HISATAKl1， Hiroshi KITAMURA1， 
Naoya MASUMORl1， Naoki ITOH1 and Taiji TSUKAMOT01 
lTheDψartment 01 Urology， Sapporo Medical University 
2TheDψartment 01 Urology， Sunagawa CiりMedicalCenter 
We evaluated the relationship between regionallymph node metastasis and tumor size in patients 
with MO renal cel carcinoma who received regional lymph node dissection. 
The study involved 234 of the 247 patients with localized renal cel carcinoma who underwent 
radical nephrectomy with lymph node dissection at our institute between 1985 and 1999. Patients 
were arbitrarily classified into 3 groups by the greatest diameter ofthe tumor on preoperative computed 
tomography (CT) : 4.0 cm or less (group A)， 4.1 to 7.0 cm (group B)， and 7.1 cm or more (group C). 
The incidence of lymph node metastasis was assessed in each group. 
The current study showed that 1 (4.7 %) of the 234 patients with lymph node dissection together 
with radical nephrectomy were lymph node positive. The incidences of lymph node metastasis were 
4.0 % in group A， 2.3 % in group B， and 8.4 % in group C (p=O. 79). Of these 11 patients with lymph 
node metastasis， 2 (18.2 %) have so far survived for over 5 years following surgery. 
Although the role of regional lymph node dissection with radical nephrectomy might be limited 
and controversial in renal cel carcinoma， urological surgeons should always be aware of possible 
metastasis for any tumor size. 
(Hinyokika Kiyo 51: 621-625， 2005) 


























対象とした症例の平均年齢59.2:!: 11. 6歳 (24-80
歳)で，観察期間の中央値は83カ月であった. リンパ
節郭清の範囲は，いわゆる limitedlymph node dis-
section 右腎癌であれば，右腎門部，傍大静脈，大
動 静脈問リンパ節，左腎癌であれば，左腎門部，傍






































(2.6%)， pT3以上では， 43例中 6例(14.0%) にリ
ンパ節転移を認めた (p<O.OJ).また， G2以下では



















Table 1. Characteristics of patients in each group 
Tumor size 
Group A (=or <40 mm) GroupB(41-70mm) GroupC(>70mm) 
p value 
No.ofpts. 75 88 71 
Mean age土SD:yrs. 57.3:1: 12.7 59.6土11.1 60.6土11.0 p=0.461) 
Sex (%) 
Male 56 (75) 55 (62) 43 (61) p=0.271) 
Female 19 (25) 33 (38) 28 (39) 
Laterarity (%) 
Right 41 (55) 50 (57) 33 (46) p=0.511) 
Left 34 (45) 38 (43) 38 (54) 
Detected pattern (%) 
Incidental 53 (71) 52 (59) 22 (31) p<O.OII) 
Non-incidental 22 (29) 36 (41) 49 (69) 
Lymph node on CT (%) 
Positive I ( 1) 17 (19) 21 (30) p=O.OII) 
Negative 74 (99) 71 (81) 50 (70) 
Median foJlow-up: mos. (range) 75.0 (8.3-211.5) 89.5 (1.5-186.2) 85.4 (1.8-167.6) p=0.591) 
1) Kruskal-WaJlis test for comparison of the characteristics between groups. Mos.: months， Yrs. : years. 
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Table 2. Pathological features and 5-year disease-specific survival of patients in each group 
Tumor size 
Group A (=or <40 mm) Group B (41-70 mm) Group C (>70 mm) 
p value 
Pathological stage) 
pT stage (%) p<O.OII) 
pTla 71 (95) 1 (1) o ( 0) 
pTlb o ( 0) 73 (83) 2 ( 3)
pT2 o ( 0) o ( 0) 44 (62) 
pT3a 3 ( 4) 3 ( 4) 6 ( 9)
pT3b 1 ( 1) 9 (10) 18 (25) 
pT3c o ( 0) o ( 0) 1 ( 1)
pT4 o ( 0) 2 ( 2) o ( 0) 
Grade (%) p<O.OII) 
GI 32 (43) 30 (34) 14(20) 
G2 40 (54) 52 (59) 42(59) 
G3 2 ( 3) 6 ( 7) 15(21) 
Unclear 
Histological type (%) p=0.761) 
Clear ceIl 65 (88) 82 (94) 66 (93) 
Spindle ceIl o ( 0) 1 ( 1) 1 ( 1)
Others 9 (12) 4 ( 5) 4 ( 6)
Not available 。
6 ( 8)
~ vs 1.l p=Q.66 
No. ofpN (+) (%) 3 ( 4) 2 ( 2) B vs C pz03.l2t J 
A vs C p=0.323) 
5-year disease-specific survival rate % 94.1 90.9 72.9 p<0.012) 
1) Kruskal-WaIis test， 2)Log-rank test， 3)Fisher's exact test， 4)according to General Rule for Clinical and Pathological Studies on 
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